Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1996
10/02/1996EP0734451A1 ENTEROTOXINS OF $i(SHIGELLA FLEXNERI) 2a
10/02/1996EP0734450A1 Methods for controlling sialic acid derivatives in recombinant glycoproteins
10/02/1996EP0734447A1 Animal model of the alzheimer disease, preparation and utilisations
10/02/1996EP0734445A1 Chimeric geens and methods for increasing the lysine content of the seeds of corn, soybean and rapeseed plants
10/02/1996EP0734443A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
10/02/1996EP0734442A1 Diagnosis of metastatic cancer by the mts-1 gene
10/02/1996EP0734441A1 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0734438A1 Method for inducing dna synthesis in neurons
10/02/1996EP0734396A1 ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY
10/02/1996EP0734395A1 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
10/02/1996EP0734394A1 Peptide inhibitors of cxc intercrine molecules
10/02/1996EP0734393A1 Method for purifying polypeptides
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996EP0734201A1 Sepsis model
10/02/1996EP0653943A4 Targeting somatic gene therapy to joints.
10/02/1996EP0597850B1 Crystalline interleukin-4
10/02/1996EP0575497B1 Dna sequences which code for virulence characteristics of -$(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by -$(s. suis) in mammals, including man
10/02/1996EP0502016B1 Novel vaccine
10/02/1996EP0487621B1 Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated n-terminal amino acids
10/02/1996EP0487617B1 Synthetic peptides that enhance cell binding
10/02/1996EP0485578B1 Neurotropic growth factors comprising a homeobox peptide
10/02/1996DE19512142A1 Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben sowie ein pharmazeutisches Produkt, das eine replizierbare Nukleinsäure enthält Infectious cDNA clone of the tick-borne encephalitis (TBE) virus derived therefrom recombinant vaccine and the preparation thereof and a pharmaceutical product containing a replicable nucleic acid
10/02/1996CN1132527A G-CSF analogue compsn. and its prepn. method
10/02/1996CN1132515A Novel peptide, active as inhibitors of platelet aggregation
10/02/1996CN1132514A Protective antigens against parasites
10/02/1996CN1132252A Antibiotic wap-8294A, method for preparing the same and antibactercal composition
10/02/1996CN1132251A Pencillin V. Amidohydrrolase gene from fusarium oxysporum
10/02/1996CN1132212A Method for crystallizing interferon alpha-2
10/02/1996CN1132211A Process for purifying hepatitis B viral surface antigen comprising PRES2 peptide
10/01/1996US5561236 Plant cell into which a gene has been introduced, the expression of which inhibits the antibiotic and herbicidal effects of bialaphos and phosphinothricin
10/01/1996US5561224 Transcription factor for regulation of the development of skin and hair
10/01/1996US5561223 DCC protein
10/01/1996US5561222 RNA-binding proteins useful for the control of cellular genetic processing and expression
10/01/1996US5561221 Methods and compositions for promoting protein folding
10/01/1996US5561220 Technetium-99m labeled peptides for imaging inflammation
10/01/1996US5561115 Therapeutic solutions
10/01/1996US5561108 Preparation of α1 -antichymotrypsin
10/01/1996US5561107 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
10/01/1996US5561064 Production of pharmaceutical-grade plasmid DNA
10/01/1996US5561063 Recombinant human cytomegalovirus containing foreign gene
10/01/1996US5561053 Dna molecule containing transcriptional regulatory regions, for genetic engineering
10/01/1996US5561046 Methods for the detection of acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
10/01/1996US5561041 Nucleic acid mutation detection by analysis of sputum
10/01/1996US5560937 Method for purification of cardiac troponin I
10/01/1996US5560936 Intrinsic inhibitors of aldose reductase
10/01/1996CA2172659A1 Fungal cell wall protein cly4
10/01/1996CA2172305A1 Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides
10/01/1996CA1338619C Lectin complex and method and probe for making same
09/1996
09/26/1996WO1996029605A2 Compounds and methods for the dectection of t. cruzi infection
09/26/1996WO1996029604A1 Method for diagnosing a patient for chlamydia
09/26/1996WO1996029593A1 Characterization of individual polymer molecules based on monomer-interface interactions
09/26/1996WO1996029433A1 Rest protein and dna
09/26/1996WO1996029429A1 System to detect protein-rna interactions
09/26/1996WO1996029425A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
09/26/1996WO1996029421A1 Vectors for gene delivery
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996029413A2 Dna encoding human papilloma virus type 18
09/26/1996WO1996029412A1 Proteinase k resistant surface protein of neisseria meningitidis
09/26/1996WO1996029411A1 Protein production and delivery
09/26/1996WO1996029410A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells
09/26/1996WO1996029409A2 Rage tumor rejection antigens
09/26/1996WO1996029408A1 Il-17 receptor
09/26/1996WO1996029407A2 Cellubrevin homologs
09/26/1996WO1996029406A2 Nuclear localization factor associated with circadian rhythms
09/26/1996WO1996029405A2 MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR
09/26/1996WO1996029404A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6
09/26/1996WO1996029403A1 Bcl2 derived genetic elements associated with sensitivity to chemotherapeutic drugs
09/26/1996WO1996029402A1 Tumor marker protein for cancer risk assessment
09/26/1996WO1996029401A1 Human b-cell translocation genes-2 and 3
09/26/1996WO1996029400A1 Method for regulating the expression of a gene in a baculovirus using a retinoic acid receptor binding site, and vector therefor
09/26/1996WO1996029396A1 Recombinant infectious laryngotracheitis virus and uses thereof
09/26/1996WO1996029367A1 Hybrid phthalocyanine derivatives and their uses
09/26/1996WO1996029348A1 Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases
09/26/1996WO1996029347A1 Thrombin inhibitors based on the amino acid sequence of hirudin
09/26/1996WO1996029346A1 Stable polymerized hemoglobin blood-substitute
09/26/1996WO1996029345A1 Novel inotropic agents
09/26/1996WO1996029344A1 Insulin derivatives
09/26/1996WO1996029343A1 Novel calcitonin derivatives
09/26/1996WO1996029342A1 Lipophilic peptide hormone derivatives
09/26/1996WO1996029341A1 Human stat4
09/26/1996WO1996029340A1 Casein phosphopeptide, casein containing same and process for the preparation thereof
09/26/1996WO1996029338A1 Identification of gene mutations associated with congenital lipoid adrenal hyperplasia
09/26/1996WO1996029090A1 Agent for influencing cell differentiation and use thereof
09/26/1996WO1996029089A1 A novel ras p21-interacting protein and uses thereof
09/26/1996WO1996029088A1 Novel piperazine derivatives as type il-1 receptor antagonists
09/26/1996WO1996029086A1 Compositions and methods for reducing adhesiveness of defective red blood cells
09/26/1996WO1996029002A1 Method of diagnosing pituitary dependent growth hormone deficiency
09/26/1996WO1996023880A3 Novel allele of human histamine h2 receptor and methods of detection of h2 receptor variants
09/26/1996WO1996023071A3 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
09/26/1996WO1996023070A3 HUMAN RETINOID X RECEPTOR - GAMMA (hRXR-GAMMA)
09/26/1996WO1996022760A3 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
09/26/1996WO1996021014A3 Production and administration of high titer recombinant retroviruses
09/26/1996WO1996020212A3 Peptide nucleic acid incorporating a chiral backbone
09/26/1996WO1996017924A3 Novel hedgehog-derived polypeptides
09/26/1996WO1996011272A3 Papilloma virus-like particles, fusion proteins and process for producing the same
09/26/1996WO1995010217A3 Functionalized aza-cryptand ligands for imaging applications
09/26/1996CA2216597A1 Method for regulating the expression of a gene in a baculovirus using a retinoic acid receptor binding site, and vector therefor
09/26/1996CA2216147A1 Cellubrevin homologs
1 ... 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 ... 2916